12


/ Press Releases
2017.04
TWi Signed a Cooperation Agreement with Intech for US Inhalation Market
2017.02
TWi Confirms Patent Challenge Relating to Its Paragraph IV ANDA Filing for a Generic Equivalent to Axiron
2017.01
TWi Settles Patent Challenge Relating to Its Paragraph IV ANDA Filing for a Generic Equivalent to Restasis
2016.12
TWi Bio is officially listed on Emerging Market of Taipei Exchange
2016.11
TWi announces the disposal of its equity investment at Visum